Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
4
×
genfit
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
autoimmune diseases
bayer
biotech
cell therapy
deals
gilead sciences
investing
merck
nonalcoholic steatohepatitis
aegle therapeutics
aligos therapeutics
What
bio
roundup
4
×
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
drug
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
aducanumab
advantages
alzheimer’s
amyloid
angst
bagged
bar
billions
biogen
biogen’s
brammer
brings
effects
expect
failure
felt
gamble
lost
Language
unset
Current search:
genfit
×
" texas blog main "
×
" detroit top stories "
×
roundup
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More